Pre-probiotic Supplementation for Post-covid Fatigue Syndrome (STOPPFATIQUE)
Long COVID
About this trial
This is an interventional supportive care trial for Long COVID focused on measuring Prebiotic, Probiotic, Metabolism, Fatigue
Eligibility Criteria
Inclusion Criteria: Age 18 - 65 years Covid-19 positive test within last 3 months (as documented byvalid PCR or antigentest Moderate-to-severe fatigue (20-MFI test total score > 43.5) At least one of additional covid-19 related symptoms (anosmia,ageusia,breathingdifficulties,lungpain, body aches, headaches, difficulties concentrating etc.) Exclusion Criteria: Other pulmonary and cardiovascular conditions History of dietary supplement use during the past 4 weeks Organic gastrointestinal (GI) disorders such as inflammatory bowel disease, coeliac disease, eosinophilic disorders, or current infection of the GI tract. Bowel surgery or short bowel syndrome. Medication or supplement which can impact the gut microbiome, including: antibiotics, antimicrobials, or antifungals in the two months Probiotic or prebiotic supplements in the last 4 weeks
Sites / Locations
- Applied Bioenergetics Lab at Faculty of Sport and PE
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Pre-probiotic
Placebo
One sachet per day during breakfast
One sachet per day during breakfast